Table 9.
Vertebral Level | Magnetic Tape® Group | Placebo Tape Group | p Value a |
---|---|---|---|
L1 postreatment first time | 6.3 ± 1.149 | 4.32 ± 0.955 | <0.001 |
L1 postreatment second time | 6.333 ± 1.15 | 4.3 ± 0.957 | <0.001 |
L2 postreatment first time | 6.35 ± 0.967 | 4.62 ± 0.55 | <0.001 |
L2 postreatment second time | 6.3 ± 0.844 | 4.62 ± 0.55 | <0.001 |
L3 postreatment first time | 6.583 ± 0.913 | 4.38 ± 0.726 | <0.001 |
L3 postreatment second time | 6.633 ± 0.956 | 4.38 ± 0.76 | <0.001 |
L4 pretreatment first time | 3.85 ± 0.602 | 3.68 ± 0.502 | <0.001 |
L4 pretreatment second time | 3.883 ± 0.688 | 3.68 ± 0.563 | <0.001 |
L4 postreatment first time | 6.567 ± 0.878 | 3.64 ± 0.483 | <0.001 |
L4 postreatment second time | 6.517 ± 0.868 | 3.62 ± 0.507 | <0.001 |
L5 postreatment first time | 6.133 ± 1.035 | 3.72 ± 0.676 | <0.001 |
L5 postreatment second time | 6.117 ± 1.042 | 3.68 ± 0.638 | <0.001 |
S1 postreatment first time | 6.75 ± 0.92 | 4.28 ± 0.642 | <0.001 |
S1 postreatment second time | 6.783 ± 0.972 | 4.32 ± 0.642 | <0.001 |
S2 postreatment first time | 6.767 ± 0.802 | 4.52 ± 0.228 | <0.001 |
S2 postreatment second time | 6.833 ± 0.812 | 4.56 ± 0.251 | <0.001 |
S3 postreatment first time | 6.8 ± 0.817 | 4.48 ± 0.295 | <0.001 |
S3 postreatment second time | 6.8 ± 0.883 | 4.54 ± 0.336 | <0.001 |
S4 postreatment first time | 6.8 ± 0.81 | 4.74 ± 0.288 | <0.001 |
S4 postreatment second time | 6.833 ± 0.821 | 4.72 ± 0.277 | <0.001 |
a showed only significant differences set at p < 0.05.